Market Share of Hepatitis Therapeutics Industry
The hepatitis therapeutics market is competitive and consists of several major players. However, in terms of market share, only a few of the major players are currently dominating the market. Some of the leading market players include Merck & Co., Inc., Gilead Sciences, Inc., AbbVie Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche, Ltd., LAURUS Labs, Zydus Cadila, Hetero Healthcare Limited, NATCO Pharma Limited, and Cipla Inc.
Hepatitis Therapeutics Market Leaders
AbbVie Inc.
Bristol Myers Squibb Company
F Hoffmann-La Roche Ltd
Gilead Sciences Inc.
Merck KGaA
*Disclaimer: Major Players sorted in no particular order
